250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in China in July 2025

A list of 50 VC (Venture Capital) funds that invest in Life science startups based in China. We rank investors based on the number of investments they made in Life science companies from China. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in China in July 2025

Investor Life Science China investments
Prox Ventures 7
Qiming Venture Partners 5
Hillhouse Investment 5
HSG 5
EFung Capital 4
Huagai Capital 4
ZSVC 3
Linear Capital 3
Legend Capital 3
Entrepreneurship Relay Group 3
CD Capital 3
WuXi AppTec 3
Vinno Capital 3
MiraclePlus 3
ULTIMA 3
BioVenture 3
CITIC Capital Holdings 3
Innoangel Fund 2
Huimei Capital 2
Gaw Capital Partners 2
Lilly Asia Ventures 2
Matrix Partners China 2
ASBV 2
Med-Fine Capital 2
Bits x Bites 2
Northern Light Venture Capital 2
Sherpa Healthcare Partners 2
BMC 2
Starlight Capital 2
CentreGold Capital 2
Danen Capital 2
Oriental Fortune Capital 2
Shunwei Capital 2
CDH Investments 2
Orient Securities Capital Investment 2
Lucion 2
Zoo Capital 2
BOHE Angel Fund 2
Rivercity Investment 2
Loyal Valley Capital 2
Hillhouse Investment 2
Haitang Fund 2
Shangshi Fund 2
Dalton Venture 2
Green Pine Capital Partners 2
Highlight Capital 2
Tianjin Venture Capital 2
Hillhouse Ventures 2
K2VC 2
Tsinghua Capital 2
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Prox Ventures VC Fund · Shanghai, Shanghai, China
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
  • Medical, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • China, United States, United Kingdom
Portfolio highlights
  • Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
  • Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 59 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
  • Tianchen Biotechnology — Tianchen Biotechnology is a biotech company that specializes in the research, design, development, and sales of ophthalmology-related medical products. It provides complete diagnostic and treatment solutions for ophthalmology.
Hillhouse Investment VC Fund · Changyang, Beijing, China · 3 investments in the past 12 months
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Series C
  • China, United States, Singapore
Portfolio highlights
  • dinii — Dinii is a mobile order platform for take-out shops.
  • Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
HSG VC Fund · Beijing, Beijing, China · 28 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Manus AI — Manus is a general AI agent that turns your thoughts into actions. It excels at various tasks in work and life, getting everything done while you rest.
  • Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
EFung Capital VC Fund · Shenzhen, Guangdong, China
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Series B, Series C
  • China, United States, India
Portfolio highlights
  • Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
  • CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
  • Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
Huagai Capital VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Germany
Portfolio highlights
  • Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
  • ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
  • Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
ZSVC VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more
Investment focus
  • Manufacturing, Health Care, Medical
  • Series A, Seed, Series B
  • China, United States, India
Portfolio highlights
  • Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
  • Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.
  • Prim Semiconductor — Prim Semiconductor specializes in ultra-high precision motion solutions, wafer transfer (EFEM), precision parts production, and comprehensive equipment research and development. The company focuses on providing integrated solutions across various sectors, including semiconductors, integrated circuit (IC) manufacturing, and new energy applications.
Linear Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
Linear Capital focuses on investment projects in the fields of Data Application, Data Infrastructure and cutting-edge technology applications. they believe that cutting-edge technology is the primary productive force, and they are committed to becoming an important promoter of cutting-edge technology landing industries, realizing FrontierTechnology,
Show more
Investment focus
  • Software, Artificial Intelligence, Biotechnology
  • Seed, Angel, Series A
  • China, Germany, Hong Kong
Portfolio highlights
  • Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
  • TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
  • NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
Legend Capital VC Fund · Beijing, Beijing, China · 21 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
  • Force Inspiration — Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robotmanufacturing and sales.
  • Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Entrepreneurship Relay Group VC Fund · Yangpu, Hainan, China · 2 investments in the past 12 months
Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more
Investment focus
  • Manufacturing, Software, Electronics
  • Series A, Funding Round, Angel
  • China
Portfolio highlights
  • Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
  • Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
  • Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
CD Capital VC Fund · Shanghai, Shanghai, China
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
  • Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
WuXi AppTec VC Fund · Shanghai, Shanghai, China
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more
Investment focus
  • Biotechnology, Pharmaceutical, Health Care
  • Series A, Series B, Series C
  • United States, China, Israel
Portfolio highlights
  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Vinno Capital VC Fund · Shenzhen, Guangdong, China · 2 investments in the past 12 months
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more
Investment focus
  • Manufacturing, Semiconductor, Hardware
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
  • Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.
  • Northern Hemisphere Technology — Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.
MiraclePlus VC Fund · Haidian, Beijing, China · 15 investments in the past 12 months
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more
Investment focus
  • Artificial Intelligence, Software, Information Technology
  • Seed, Angel, Pre-Seed
  • China, United States, Singapore
Portfolio highlights
  • TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
  • Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
  • Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
ULTIMA VC Fund · Chengdu, Sichuan, China
ULTIMA is an investment management firm.
Show more
Investment focus
  • Hardware, Software, Agriculture
  • Angel, Series A
  • China
Portfolio highlights
  • Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
BioVenture VC Fund · Suzhou, Jiangsu, China · 8 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • Hengyu Medical — Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
CITIC Capital Holdings VC Fund · Central, Hong Kong Island, Hong Kong · 2 investments in the past 12 months
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more
Investment focus
  • Manufacturing, Health Care, E-Commerce
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Xiaohongshu — Xiaohongshu is a lifestyle-sharing platform for users to share positive energy and good life through the sharing of text, pictures, and videos. Xiaohongshu offers an overseas shopping tip app. Xiaohongshu started its business by helping overseas travelers to draft a shopping list before they hit the roads. But with the aggregation of more UGCcontent, the service is transforming into a community for those who are passionate about fashion and shopping and want to know more about these fields even though they do not have overseas traveling plans on their schedules.
  • Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
  • Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
Innoangel Fund VC Fund · Beijing, Beijing, China · 21 investments in the past 12 months
Innoangel Fund is an investment firm that invests in early stage companies.
Show more
Investment focus
  • Artificial Intelligence, Manufacturing, Robotics
  • Angel, Seed, Series A
  • China, Canada, Hong Kong
Portfolio highlights
  • Optoseeker — Optoseeker is an innovative technology designed to empower advancements in life sciences by providing cutting-edge solutions for biomedicine and cell and gene therapy, and accelerating the transformation of scientific research.
  • Accelerating Evolution — Accelerating Evolution is a humanoid robotics company. It provides humanoid robots to AI firms and research institutes, as well as quick mass production and supply of standard items.
  • Dingou Biopharmaceuticals — Dingou Biotechnology is a developer of allergen diagnosis and treatment products, mainly engaged in allergen-specific diagnosis and treatment business
Huimei Capital VC Fund · Beijing, Beijing, China · 2 investments in the past 12 months
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
  • Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
  • Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Gaw Capital Partners VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in the past 12 months
Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.
Show more
Investment focus
  • Real Estate, Property Management, Hospitality
  • Series A, Series C, Seed
  • China, Singapore, United States
Portfolio highlights
  • Placemakr — WhyHotel is an alternative lodging service company that operates pop-up hotels in newly built, luxury apartment buildings. The hotels offer fully furnished apartments that combine the comforts of home, the services of a hotel and the amenities of newly built, luxury apartment buildings. WhyHotel allows multifamily developers to de-risk the lease-upphase of new assets and creates a new revenue stream while serving as an added amenity for residents.
  • Blackpanda — Asia's premier digital forensics and cyber incident response firm.
  • NPX Point Avenue — NPX Point Avenue is an education technology company focused on the fast-growing K-12 private international school market and K-12 after-school training market.
Lilly Asia Ventures VC Fund · Shanghai, Shanghai, China · 10 investments in the past 12 months
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
  • Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
  • Timberlyne Therapeutics — Taking Best-in-Class Therapies to New Heights Our mission is to bring life-changing medicines to patients living with autoimmune diseases. About Us Timberlyne Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of transformational therapies for autoimmune diseases. We are leveraging the extensive drug development expertise
Matrix Partners China VC Fund · Beijing, Beijing, China · 12 investments in the past 12 months
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Sand.ai — Sand AI is an AI company that focuses on producing videos.
  • TOYA — TOYA specializes in the production of ultra-fine copper and copper alloy conductors.
  • LeXiang Intelligence — LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.
ASBV VC Fund · Shenzhen, Guangdong, China
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Angel
  • China, Australia, Hong Kong
Portfolio highlights
  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Med-Fine Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
  • Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Bits x Bites VC Fund · Shanghai, Shanghai, China
Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.
Show more
Investment focus
  • Biotechnology, Food and Beverage, Food Processing
  • Series A, Seed, Series B
  • China, Israel, Singapore
Portfolio highlights
  • Cataya Bio — Cataya Bio (Shanghai) Co., Ltd. is a product company powered by an advanced engineering biology platform and biomanufacturing. We engineer microbes and develop clean fermentation processes to manufacture products of high purity, at low cost, and in a sustainable way. We strive to help the world to transition away from petroleum and addressimportant global issues in environmental preservation, carbon emission and climate change.
  • Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
  • Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Northern Light Venture Capital VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, South Korea
Portfolio highlights
  • VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
  • AscentStream — AscentStream is a software development company that provides cloud messaging software and stream processing solutions.
  • Shengrun New Materials — Shengrun New Materials is an aerogel material and system solution service provider integrating advanced material process research and development, product application development, advanced production line design, and mature system solutions.
Sherpa Healthcare Partners VC Fund · Beijing, Beijing, China · 8 investments in the past 12 months
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Kenya
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • PAQ Therapeutics — PAQ Therapeutics is developing KRAS degraders for deadly cancers without good treatment options.
  • Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
BMC VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months
BMC engaged in asset management, investment management and consulting.
Show more
Investment focus
  • CAD, Medical, Computer
  • Seed, Series B
  • China
Portfolio highlights
  • Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
  • Jingyao Xinhui Semiconductor — Jingyao Xinhui Semiconductor is the indium phosphide optical chip manufacturer company.
  • Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.
Starlight Capital VC Fund · Pudong, Shandong, China · 3 investments in the past 12 months
Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.
Show more
Investment focus
  • Manufacturing, Robotics, Software
  • Series A, Series C, Series B
  • China
Portfolio highlights
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • Wanxun Technology — Wanxun Technology is a service robot developer dedicated to flexible, dexterous and interactive service robots for industries and families.
  • Kedian Intelligent Cloud — Kedian Intelligent Cloud is an innovative enterprise focusing on the field of industrial hemp.
CentreGold Capital VC Fund · Fremont, California, United States
Our team invests in early-stage digital health and consumer startups at CentreGold Capital.
Show more
Investment focus
  • Medical Device, Artificial Intelligence, Internet
  • Seed, Series A, Angel
  • United States, China, Canada
Portfolio highlights
  • Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
  • Virgo Surgical Video Solutions — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
  • WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
Danen Capital VC Fund · Shenzhen, Guangdong, China
Danen Ventures is an early-stage venture capital firm that focuses on high-growth fields, such as information technology and internet, renewable energy and environmental, advanced manufacturing industry, biotechnology and medical science, and healthcare.
Show more
Investment focus
  • B2B, Fashion, Medical
  • Series A, Angel, Seed
  • China, United States
Portfolio highlights
  • CartaBio — CartaBio is an authorised spatial omics technology platform. CartaBio specializes in the creation of AI-integrated solutions for the biotech industry, including scission-accelerated fluorophore exchange and the multimodal CellBERT model.
  • SynMetaBio — SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather.
  • Meiyou Technology — Meiyou Technology is a DNA synthesizer developer focusing on enzymatic long-fragment DNA synthesis and splicing technology. They use high-throughput synthesizers to reduce DNA synthesis costs and offer gene design services for the biotechnology industry.
Oriental Fortune Capital VC Fund · Shenzhen, Guangdong, China · 4 investments in the past 12 months
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
  • Software, Manufacturing, Information Technology
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
  • Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.
  • Gongjin Microelectronics — Gongjin Microelectronics develops and manufactures electronic components and semiconductor solutions for various industries.
Shunwei Capital VC Fund · Beijing, Beijing, China · 22 investments in the past 12 months
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more
Investment focus
  • Manufacturing, Software, Internet
  • Series A, Series B, Series C
  • China, India, United States
Portfolio highlights
  • LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
  • Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
  • Fanding International Group — Fanding International Group offers supply chain services by reducing logistics costs.
CDH Investments VC Fund · Kowloon City, Kowloon, Hong Kong · 20 investments in the past 12 months
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
  • Manufacturing, Biotechnology, Health Care
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • Robot Era — Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes.
  • Tiejin Technology — Tiejin Technology is a humanoid robotics company that provides research and development related to micro and ultra-micro bearings.
  • Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
Orient Securities Capital Investment VC Fund · Shanghai, Shanghai, China · 3 investments in the past 12 months
Orient Securities Capital Investment is an private equity fund business platform.
Show more
Investment focus
  • Manufacturing, Health Care, Medical
  • Series A, Funding Round, Series B
  • China
Portfolio highlights
  • Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
  • Xinhui Lianxin — Xinhui Lianxin is an electronic component manufacturer, mainly engaged in the manufacturing of special equipment for semiconductor devices, semiconductor discrete devices, power electronic components, integrated circuit manufacturing, integrated circuit chips and product manufacturing.
  • Haifu Technology — Haifu Technology is a high-tech company specializing in automobile manufacturing and robotics.
Lucion VC Fund · Jinan, Shandong, China · 6 investments in the past 12 months
Lucion is an influential professional venture capital institute.
Show more
Investment focus
  • Biotechnology, Medical, Manufacturing
  • Series A, Series B, Seed
  • China
Portfolio highlights
  • Insyce — Inces is an innovative high-tech enterprise focusing on bio-separation technology.
  • Ubinexus — Ubinexus focuses on the overall design capabilities of satellite communication payloads and satellite-based comprehensive digital processing technology to meet the multi-dimensional needs of low-orbit mega-constellation construction and provide users with the world's leading communication payload system.
  • Uni-Sentry — Uni-Sentry offers information security testing tool chain and information security compliance testing platform for intelligent networked vehicles, vehicle information security penetration testing services, autonomous driving GNSS anti-spoofing anomaly detection solutions, National secret algorithm vehicle hardware security module HSM solution.
Zoo Capital VC Fund · Beijing, Beijing, China
Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.
Show more
Investment focus
  • Artificial Intelligence, Software, Biotechnology
  • Seed, Series A, Series B
  • China, Hong Kong, United States
Portfolio highlights
  • TabbyML — Tabby is an open-source AI coding assistant that empowers developers to code faster and smarter. Discover a self-contained alternative to GitHub Copilot, tailored for your development needs.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.
BOHE Angel Fund VC Fund · Suzhou, Jiangsu, China · 2 investments in the past 12 months
BOHE Angel Fund is an investment Fund.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Angel, Series A, Seed
  • China
Portfolio highlights
  • QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
  • Tyligand Bioscience — Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes.
  • Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Rivercity Investment VC Fund · Wuhan, Hubei, China · 5 investments in the past 12 months
Ruijiang Investment is a market-oriented, professional and international fund management company focusing on equity investment funds, industrial investment funds and asset management business, with a management scale of more than 2 billion yuan.
Show more
Investment focus
  • Medical, Biotechnology, Electronics
  • Seed, Series A, Series C
  • China
Portfolio highlights
  • Tuo Rui Jing — Tuo Rui Jing is a global molecular diagnostic company with technological innovation at its core.
  • Ruixun Biotech — Ruixun Biotech is a Healthcare company.
  • Qianjue Technology — Qianjue Technology is a company that created the first full-stack application-level robot model and offers cloud-based artificial intelligence solutions to robot manufacturers.
Loyal Valley Capital VC Fund · Shanghai, Shanghai, China
Loyal Valley Capital is a thematic, research-driven private equity firm.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series C, Series B, Series A
  • China, United States, Hong Kong
Portfolio highlights
  • DP Technology — DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D.DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trainedlarge science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.
  • DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.
  • Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Hillhouse Investment VC Fund · Singapore, Central Region, Singapore · 6 investments in the past 12 months
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
  • Manufacturing, Software, Biotechnology
  • Series A, Series B, Series C
  • China, United States, Singapore
Portfolio highlights
  • dinii — Dinii is a mobile order platform for take-out shops.
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Haitang Fund VC Fund · Nankai, Tianjin, China · 4 investments in the past 12 months
Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.
Show more
Investment focus
  • Manufacturing, Biotechnology, Medical
  • Funding Round, Seed, Series A
  • China
Portfolio highlights
  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Hengyu Medical — Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
  • HurRain NanoTech — HurRain NanoTech is a new functional nanomaterials service provider for atmospheric water generation solutions. It developed a platform for material screening and amplification with functional composite moisture-absorbing interfacial thermal materials as the primary R&D direction, created a product line of atmospheric water generator devicesand interfacial thermal materials, and provided customers with standardized products and solutions.
Shangshi Fund VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months
Shangshi Fund is an investment firm.
Show more
Investment focus
  • Information Technology, Hardware, Electronics
  • Series A, Angel, Series B
  • China
Portfolio highlights
  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Infinigence — Wuwen Core Dome is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
  • HurRain NanoTech — HurRain NanoTech is a new functional nanomaterials service provider for atmospheric water generation solutions. It developed a platform for material screening and amplification with functional composite moisture-absorbing interfacial thermal materials as the primary R&D direction, created a product line of atmospheric water generator devicesand interfacial thermal materials, and provided customers with standardized products and solutions.
Dalton Venture VC Fund · Shanghai, Shanghai, China · 8 investments in the past 12 months
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Series B
  • India, China, Canada
Portfolio highlights
  • Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Green Pine Capital Partners VC Fund · Shenzhen, Guangdong, China · 4 investments in the past 12 months
Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.
Show more
Investment focus
  • Software, Artificial Intelligence, Manufacturing
  • Series A, Series B, Angel
  • China, United States, Canada
Portfolio highlights
  • Readline — Readline is a biological immobilized enzyme catalysis technology application service provider.
  • Taifang Technology — ## Build Setup
  • NAEN Auto Technology — Shanghai NAEN Auto Technology co.Ltd provides automotive electronics products for automobile manufacturers.
Highlight Capital VC Fund · Nanjin, Jiangsu, China · 21 investments in the past 12 months
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Portugal
Portfolio highlights
  • ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
  • Shenandoah Therapeutics — Shenandoah Therapeutics is a biotechnology company.
Tianjin Venture Capital VC Fund · Tianjin, Guangdong, China · 4 investments in the past 12 months
Tianjin Venture Capital is an investment firm.
Show more
Investment focus
  • Manufacturing, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • China, United States
Portfolio highlights
  • Guangyi Aviation — Guangyi Aviation is a technology business that specializes in the research and development of high-performance electric multi-stage ducted engines and ducted large-load UAVs. Its mission is to promote the creation and implementation of all-electric aviation technology.
  • Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
  • Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.
Hillhouse Ventures VC Fund · Singapore, Central Region, Singapore · 11 investments in the past 12 months
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more
Investment focus
  • Manufacturing, Biotechnology, Health Care
  • Series A, Series B, Seed
  • China, Singapore, Norway
Portfolio highlights
  • TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
  • Xinyanyi Code — Xinyanyi Code is an artificial intelligence programming application service provider that focuses on AI Coding and benchmarks the American intelligent code generation product Cursor.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
K2VC VC Fund · Beijing, Beijing, China · 11 investments in the past 12 months
K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.
Show more
Investment focus
  • E-Commerce, Manufacturing, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Japan
Portfolio highlights
  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
  • Xijia Medical — Xijia Medical is a brain science AI technology developer dedicated to individualized brain data analysis and brain disease research.
  • Yujia Power Technology — Yujia Power is focused on aircraft electrification and offers comprehensive solutions for fundamental goods such as motors and controls.
Tsinghua Capital VC Fund · Haidian, Beijing, China · 17 investments in the past 12 months
Tsinghua Capital is an investment firm.
Show more
Investment focus
  • Manufacturing, Artificial Intelligence, Biotechnology
  • Seed, Angel, Series A
  • China, Australia
Portfolio highlights
  • LightSail Technology — LightSail Technology is a professional Internet marketing service provider, focusing on Internet marketing and brand operation.
  • Interstellar Lightyear — Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands, focusing on creating intelligent dexterous hands with advanced capabilities for precise manipulation.
  • CP Food Power Technology — CP Food Power Technology is a food technology company that specializes in smart food machine supply chain system solutions.
Investors by industry
Investors by country
VC (Venture Capital) Funds in China by industry